Impact of super-spreaders on COVID-19
systematic review
Keywords:
Coronavirus infections, COVID-19 [supplementary concept], PandemicsAbstract
BACKGROUND: Spreader and super-spreader are terms that refer to people who have greater potential for disease transmission, to infect other people. OBJECTIVE: To present scientific evidence regarding the impact of COVID-19 spreaders. DESIGN AND SETTING: Systematic review of the literature (using the PRISMA framework), performed at the Federal University of Santa Catarina (UFSC), Florianópolis (SC), Brazil. METHODS: A search for articles was carried out in the SciELO, LILACS, PubMed, Scopus, Bireme and Web of Science databases. A search for gray literature was also conducted via Google Scholar. There was no restriction regarding place or language, and the search covered the period from January 2010 to August 2020. Studies were selected based on a combination of descriptors from the Medical Subject Headings (MeSH). RESULTS: Isolated cases of people diagnosed with COVID-19 who were classified as super-spreaders were found. They had been classified thus because they may have had greater potential for infecting other individuals. However, greater numbers of interventions are needed in order to identify and manage COVID-19 cases. There is little evidence regarding this detection, which further hinders recognition and understand- ing of super-spreading events. CONCLUSION: The scientific community needs greater depth of evaluation and understanding of how these patients physiologically develop the ability to propagate COVID-19 more intensely. A simpler way of tracking them is also necessary, given that many infected people are asymptomatic. Many patients also have mild symptoms, suggesting that these individuals could also be classified as possible COVID-19 spreaders. PROSPERO NUMBER: ID 217874 (submitted for publication and is being assessed by the editorial team).
Downloads
References
Lima CMAO. Information about the new coronavirus disease (COVID-19). Radiol Bras. 2020;53(2):V-VI. PMID: 32336833; http://doi.org/10.1590/0100-3984.2020.53.2e1.
Chakraborty C, Sharma AR, Sharma G, Bhattacharya M, Lee SS. SARS- CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options. Eur Rev Med Pharmacol Sci. 2020;24(7):4016-26. PMID: 32329877; http://doi.org/10.26355/eurrev_202004_20871.
Cave E. COVID-19 Super-spreaders: Definitional Quandaries and Implications. Asian Bioeth Rev. 2020;1-8. PMID: 32427202; https://doi.org/10.1007/s41649-020-00118-2. Epub ahead of print.
Ebrahim SH, Memish ZA. COVID-19: preparing for superspreader potential among Umrah pilgrims to Saudi Arabia. Lancet. 2020;395(10227):e48. PMID: 32113506; http://doi.org/10.1016/S0140-6736(20)30466-9.
Sun P, Lu X, Xu C, Sun W, Pan B. Understanding of COVID-19 based on current evidence. J Med Virol. 2020;92(6):548-51. PMID: 32096567; http://doi.org/10.1002/jmv.25722.
World Health Organization. Coronavirus disease (COVID-19) pandemic. 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019?gclid=CjwKCAiAt9z-BRBCEiwA_bWv-GwYhjwaHvhG9gJ2EamOZCPWN9JiVvzSwzaPThUwD2HarBH3fogUBoCUJoQAvD_BwE. Accessed in 2020 (Oct 28).
Speth MM, Singer-Cornelius T, Oberle M, et al. Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics. Otolaryngol Head Neck Surg. 2020;163(1):114- 20. PMID: 32423357; http://doi.org/10.1177/0194599820929185.